MedTrace Logo

Prevalence and Hematological Characteristics of Hemoglobinopathies

NCT07180836 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 839

Last updated 2025-09-18

No results posted yet for this study

Summary

This study aimed to determine the prevalence and hematological characteristics of hemoglobinopathies in Mardan and surrounding districts of Khyber Pakhtunkhwa (KPK), Pakistan. A descriptive cross-sectional design was conducted at Mardan Medical Complex from January 2021 to January 2023. Blood samples were analyzed using High Performance Liquid Chromatography (HPLC) on the Bio-Rad D-10 analyzer, with complete blood counts performed using Sysmex XN1000. A total of 839 participants were enrolled in this study. The study highlights differences in hematological parameters across hemoglobinopathy types and provides region-specific data to inform public health interventions and screening programs.

Conditions

  • Hemoglobinopathies

Interventions

OTHER

No Intervention (Observational Study)

This is an observational, cross-sectional study. Patients with suspected or confirmed hemoglobinopathies were evaluated for prevalence and hematological characteristics using laboratory investigations, without any experimental treatment or therapeutic intervention applied.

Sponsors & Collaborators

  • Bacha Khan Medical College

    lead OTHER

Principal Investigators

  • Malik Shayan Ali Khan, MBBS · Bacha Khan Medical College, Mardan.

Eligibility

Min Age
1 Year
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-15
Primary Completion
2023-01-15
Completion
2023-01-20

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07180836 on ClinicalTrials.gov